Evolus Q4 2023 GAAP EPS $(0.210) Misses $(0.200) Estimate, Sales $60.999M Beat $60.056M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolus (NASDAQ:EOLS) reported Q4 2023 earnings with a GAAP EPS of $(0.210), missing the $(0.200) estimate, but sales of $60.999M exceeded the $60.056M forecast. This represents an 8.7% decrease in losses per share and a 39.76% increase in sales compared to the same period last year.

March 07, 2024 | 9:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evolus reported a slight miss on EPS estimates but exceeded sales forecasts for Q4 2023, indicating strong sales growth.
While the miss on EPS estimates might concern some investors, the significant beat on sales forecasts and the substantial year-over-year sales growth could indicate strong underlying business performance. This mixed result could lead to neutral short-term stock price movement as investors weigh the EPS miss against the strong sales performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100